This compound is a deuterated pharmaceutical intermediate, specifically a trideuteriomethoxy-substituted carbamate derivative. It is used in the manufacturing of pharmaceuticals where deuterium incorporation is desired.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1346600-86-9
Benzyl-d7 alcohol
deuterated pharmaceutical intermediate
N,N-Dimethylacetamide-d9
deuterated pharmaceutical intermediate
1-Adamantan-d15-amine
deuterated pharmaceutical intermediate
Ethane-d5, iodo-
deuterated pharmaceutical intermediate
Allopurinol Impurity C
Pharmaceutical impurity reference standard
3-Amino-4-(2-chlorophenyl)-6-nitro-2(1H)-quinolinone
Pharmaceutical intermediate for impurity synthesis
3-Amino-6-chloro-4-(4-pyridinyl)-2-quinolinone Hydrazone
Pharmaceutical intermediate for alprazolam impurities
(2R,3S)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid
Pharmaceutical intermediate
[2-hydroxy-3-[2-(trideuteriomethoxy)phenoxy]propyl] carbamate
GNXFOGHNGIVQEH-FIBGUPNXSA-N
[2H]C([2H])([2H])OC1=CC=CC=C1OCC(COC(=O)N)O
—